COVID-19 Vaccine

COVID-19 Vaccine



Seniors 65+ ONLY
Complete the online Waitlist Registration Link to be put on a waiting list.

The link appears as a scheduling assistant. You are required to select a date and time to move to the next section. PLEASE NOTE: THIS IS NOT AN APPOINTMENT FOR THE VACCINE. IT IS TO ONLY BE PUT YOU ON THE WAITING LIST. Once vaccine is available you will receive a scheduled appointment email with your appointment date, time and location. DO NOT ALSO CALL THE HOTLINE TO SCHEDULE AS THIS WILL DUPLICATE YOUR ENTRY. DHD#10 is partnering with the Area Agency on Aging, senior centers, and other partners to assist this effort.

Seniors 65+ ONLY
Call this hotline number:
to be placed on a waiting list

This hotline is only for older adults who are not in contact with a community agency. Once you are on the waiting list, you will be contacted as more vaccine is available and you can be scheduled.



Please do not call our offices regarding vaccination unless absolutely necessary. Our phone lines are overloaded with calls and we need our staff to plan and run vaccine clinics. 

If you have a scheduled appointment, you can assist us with filling out the paperwork prior to coming for your appointment. Fill out this form and bring it with you to your appointment. If you do not have access to a printer, you can fill it out when you arrive to your appointment. THIS FORM IS NOT FOR REGISTERING AN APPOINTMENT. IT IS ONLY THE PAPERWORK NEEDED TO RECEIVE YOUR VACCINE WHEN YOU ARE SCHEDULED.



Please sign up for our Public Health Alert to receive the most up to date information on the COVID-19 vaccine.

District Health Department #10 continues to vaccinate individuals in Phase 1A of the priority group. As we are now on a schedule to receive additional vaccine weekly, and under MDHHS recommendations, we are expanding our effort to all of Phase 1A priority groups.  Clinics are scheduled this week for the health care provider priority group in Phase 1A and from they will be on a rolling weekly schedule. 

Because our vaccine supply is severely limited, we are targeting our efforts to the highest risk workers until the supply picks up and are asking that health care providers adhere to only registering staff who have direct patient contact. As our vaccines pick up, and as we receive second dose allotments, we will increase clinics to meet the new need including non-traditional clinic days/hours. While vaccine supplies are limited, vaccine clinics are invite-only and are scheduled at specific times. They are not walk-in vaccination clinics.

PHASE 1A includes: Paid and unpaid persons serving in health care settings who have the potential for direct or indirect exposure to patients or infectious materials and are unable to work from home as well as residents in long-term care facilities.

Phase 1A is broken down to three priority groups:

  • Priority One: Keep critical health care infrastructure open and functioning (i.e., hospitals, critical care units, and emergency medical response systems) through vaccination of staff who perform direct patient care and work in critical areas including:
    • Group A: Emergency medical service providers, including medical first responders
    • Group B: General medical floor
    • Group C: Emergency department
    • Group D: Intensive care units
  • Priority Two: Prevent outbreaks and protect residents in long-term care facilities.
    • Group A: Vaccinate workers who have direct contact with large number of vulnerable residents. Note this would include staff who come in and out of the buildings.
      • Skilled nursing facility staff
      • Psychiatric hospital staff
      • Homes for aged staff
      • Adult foster care centers staff
      • Assisted living facility staff
      • Home health care workers caring for high-risk clients with large patient loads (e.g. people with a tracheostomy/ventilator at home)
    • Group B: Vaccinate vulnerable residents in long-term care facilities
      • Skilled nursing facility residents
      • Psychiatric hospitals patients
      • Homes for aged residents
      • Adult foster care centers residents
      • Assisted living facility residents
  • Priority Three: Keep necessary health care infrastructure functioning.
    • Group A: Vaccinate workers with direct patient contact who conduct high risk procedures (e.g., dentists, endoscopy, dialysis).
    • Group B: Vaccinate other workers who have direct patient contact, including outpatient, urgent care, ambulatory care, and home health care.
    • Group C: Vaccinate workers with specialized skills critical to health care system functioning who have indirect patient contact (e.g. hospital and public health laboratories, pharmacy, and medical waste handlers).


DHD#10 is currently working on planning for Phase 1B vaccination clinics. We will launch a pre-registration process for individuals to schedule their vaccine and will notify those in Phase 1B when it is launched. Again, while vaccine supplies are limited, vaccine clinics are invite-only and are scheduled at specific times. They are not walk-in vaccination clinics. PLEASE NOTE: Pre-registration for Phase 1B has not launched yet. There is no early registration or sign-up. We will notify the public via press release, social media, our website at,  and our Public Health Alert. If you have not subscribed to our Public Health Alert, please do so at We ask for your patience as we prepare for Phase 1B.

PHASE 1B includes

  • Age 65 and up
  • Front Line First Responders including:
    • Police (state and local)
    • Fire
    • Corrections and County Jail Workers
    • Childcare
    • Pre-K through 12 teachers and those staff in schools who have direct contact with children
    • Adult and child protective services 
    • Homeless shelter staff

Phase 1C includes:

  • The remainder of essential workers including:
    • Food and agriculture workers
    • Critical manufacturing workers
    • U.S. Postal Service workers
    • Public transit workers
    • Grocery store workers
    • Workers in homeless shelters, congregate child care institutions, and adult and child protective services
    • Workers with unique skill sets not covered above, such as non-hospital laboratories and mortuary services
  • Individuals age 16 to 64 years at high risk of severe illness due to COVID-19 infection and some other essential workers whose position impacts life, safety and protection during the COVID-19 response
  • Individuals age 16 to 64 years with COPD, hypertension, chronic kidney disease, heart disease, diabetes, obesity or other conditions that puts them at high risk of negative COVID-19 outcome.
  • Essential workers whose work must be performed on site, not covered in prior Phases, will also likely be vaccinated during this phase.

MDHHS will adapt this guidance as vaccine availability becomes clearer.

Phase 2 includes:

  • Individuals 16 years of age or older.

These prioritizations may change as more information on vaccine effectiveness and additional vaccination products become available. MDHHS has provided additional prioritization guidance within these categories. It is important to note that vaccination in one phase may not be complete before vaccination in another phase begins. There may be vaccination of individuals in different phases that occur simultaneously. The timing of the start of vaccination in a phase is dependent on the supply of vaccine from the manufacturer, how vaccine is allocated from the federal level to Michigan and the capacity to administer the vaccine to populations. Decisions on moving to the next phase will be made at the state level.


The supply of vaccines will continually increase in the weeks and months that follow until everyone is able to receive a vaccine. Vaccines may not be recommended for children. Cost will not be an obstacle to getting vaccinated against COVID-19. Following vaccination, measures to stop the spread of the SARS-CoV-2 virus, such as masks and social distancing, will still be needed. 

In an effort to provide more insight, DHD#10 Medical Director, Dr. Jennifer Morse, produced some helpful videos on the mRNA vaccine and on the development and safety of the COVID-19 vaccine. 

Infographic on developing the COVID-19 vaccine
Infographic on mRNA vaccine


For the most up-to-date data on COVID-19 Vaccine distribution, MDHHS now has a COVID-19 Vaccine Dashboard. MDHHS is tracking the number of enrolled providers, vaccines shipped, doses administered, and doses by vaccine. You can see the numbers overall for the state, or select your region, local health department, provider, or county for more detailed information.



When will the vaccine be available?

Michigan is expected to receive a limited amount of vaccine by mid-December 2020. Due to the limited supply, MDHHS will have to prioritize how the vaccine will be distributed. Supply of the vaccine will increase substantially over the next few months. Those eligible to receive the vaccine will change as supply increases.

Who will get the vaccine first?

Distribution of the vaccine in Michigan will be in a phased approach because it will be several months before supply increases enough to vaccinate everyone.

The Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) have defined different vaccination phases. The ACIP recently voted on allocating initial supplies of COVID-19 vaccine. These recommendations review who is recommended to receive the first phase of the COVID-19 vaccine. For further information review, The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine.

Michigan has prioritized vaccine allocation within CDC phases, with an emphasis on both ensuring the continuing functioning of the health care system and essential services in the community and protecting people at increased risk for severe COVID-19 illness. These prioritizations may change as more information on vaccine effectiveness and additional vaccination products become available.

It is important to note that vaccination in one phase may not be complete before vaccination in another phase begins. There may be vaccination of individuals in different phases that occurs simultaneously. The timing of the start of vaccination in a phase is dependent on the supply of vaccine from the manufacturer, how vaccine is allocated from the federal level to Michigan, and the capacity to administer the vaccine to populations.

MDHHS has created interim guidance for partners on how to prioritize vaccine within these phases.

When will the vaccine be available to the general public?

The vaccine will be available to the general public when supply substantially increases in 2021. Until the supply substantially increases, priority will be given to health care providers, essential workers, and vulnerable populations (i.e., adults 65 years of age and older and adults with high risk medical conditions).

Will homeless people receive the vaccine?

Yes. Local health departments will coordinate with Federally Qualified Health Centers to administer the vaccine to homeless individuals.

Will tribal populations receive the vaccine?

Yes. Vaccine will be administered to tribal members through their tribal health clinics.

Will migrant workers receive the vaccine?

Yes. Local health departments will coordinate with Federally Qualified Health Centers to administer the vaccine.

Is there a cost to get vaccinated?

No fees will be charged to get vaccinated. There will be no cost sharing from insurance plans. Vaccine doses purchased with U.S. taxpayer dollars will be given to the American people at no cost. COVID-19 providers agree to administer vaccine regardless of an individual’s ability to pay and regardless of their coverage status, and may not seek any reimbursement, including through balance billing, from a vaccine recipient. However, vaccine providers will be able to charge administration fees for giving or administering the shot to someone. Vaccine providers can get this fee reimbursed by the patient’s public or private insurance company or, for uninsured patients, by the Health Resources and Services Administration’s Provider Relief Fund.

Will more than one dose of COVID-19 Vaccine be required?

Yes. All but one of the COVID-19 vaccines currently in Phase 3 clinical trials in the United States need two shots to be effective. It is very important that you get both doses within the required time frame to ensure the best protection from COVID-19.

How will I be reminded to get the second dose?

MDHHS plans to use multiple ways to notify you of your second dose. COVID-19 vaccination record cards (reminder cards) will be provided to you when you receive the COVID-19 vaccine. The card provides room for a written reminder for a second-dose appointment. If you have a smartphone, consider taking a photo of your vaccination record and entering the date the next vaccine dose is due in your calendar. MDHHS is also developing text messaging reminders that will be sent prior to your second dose. In addition, health care providers or health systems may also have other methods in place to help remind you of when to return for your second dose.

Again, to ensure the best protection from COVID-19, it is very important to not skip the second dose. The second dose must be from the same vaccine manufacturer, so it will be important to ensure that where you receive your second dose has the right vaccine. If you can, it would be best to follow up with the same provider who gave you your first shot.

Can any doctor’s office, clinic, or pharmacy offer the COVID-19 vaccine?

Doctor’s offices, clinics, and pharmacies who are enrolled in the vaccination program can offer the vaccine when the vaccine becomes available to them. Initially the federal government will distribute a limited supply of vaccine to each state. Michigan will allocate this limited supply to hospitals and health care settings where workers have contact with patients. Later distribution will be coordinated through local health departments, and eventually as supply increases doctor’s offices, clinics, and pharmacies will be able to obtain the vaccine directly.

Will people who have already had COVID-19 be able to get vaccinated?

There is not enough information currently available to say if or for how long after infection someone is protected from getting COVID-19 again; this is called natural immunity. Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. Until we have a vaccine available and the Advisory Committee on Immunization Practices (ACIP) makes recommendations to CDC on how to best use COVID-19 vaccines, there will not be any information available on whether people who had COVID-19 should get a COVID-19 vaccine.
More information is available on the CDC website in their FAQ document.

Is the vaccine safe?

We understand that some people may be concerned about getting vaccinated once a COVID-19 vaccine is available in the United States. The process used to approve the COVID-19 vaccines is the same proven process that was used to create safe and effective vaccines for the flu, polio, measles, pertussis (whooping cough) and more. While these vaccines are being developed as quickly as possible through the help of global cooperation and unprecedented public and private funding, our routine processes and procedures remain in place to ensure the safety of any vaccine that is authorized or approved for use. Safety is a top priority. The U.S. vaccine safety system ensures that all vaccines are as safe as possible.

How can a safe vaccine be made so quickly?

Vaccine development typically takes many years. However, scientists had already begun research for coronavirus vaccines during previous outbreaks caused by related coronaviruses such as SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome). That earlier research provided a head start for rapid development of vaccines to protect against infection with COVID-19. Additional steps were also taken to shorten the timeline without sacrificing safety such as:
• Overlapping phase I and phase II clinical trials. Phase I studies include a small number of people and evaluate whether the vaccine causes an immune response and is safe. Scientists could look at data from a group of people as phase II was progressing to make these evaluations.
• While completing large phase III trials, manufacturers began producing the vaccine, so that if it were shown to be safe and effective, they would have large numbers of doses ready. This is not normally done because if the vaccine does not work, the manufacturer will have spent a significant amount of money to produce something that needs to be thrown away.
• Traditional vaccine production involves growing viruses in living cells and purifying the virus. There are challenges associated with this process that takes time. The mRNA vaccine has an advantage in that large amounts of the mRNA can be synthesized very rapidly.
• While waiting for a vaccine to be ready, many other aspects of vaccine delivery were prepared (e.g., developing plans for how to distribute the first, limited quantities available, ensuring adequate supplies for distributing and administering vaccine.)

Does the vaccine have any side effects?

Most people do not have serious problems after being vaccinated. We will understand more about mild side effects of the COVID-19 vaccine before we start to use it and as the vaccine recommendations come out.
Some studies have begun to show that COVID-19 vaccines may give the person a stronger immune response than other vaccines that people are familiar with. Your arm may be sore, red, or warm to the touch. You may experience a low-grade fever, headache, and just a general feeling of “not yourself”. These are signs that your immune system is doing exactly what it is supposed to, which is produce an immune response for you to have protection against disease. This is a normal response in the process of your body building immunity.

What information will be collected about me when I receive the vaccine?

When vaccines are administered your name, address, and vaccine given are required to be reported to the Michigan Care Improvement Registry (MCIR) which is the state’s immunization registry.

Will information collected about me be shared with anyone?

Providers and local health departments who have access to the MCIR (after signing the required MCIR Usage agreement that governs protection of the information) can view a person’s record to know what vaccines they have received.

What information will be shared? With whom?

Michigan will share vaccination information with the CDC but in de-identified aggregate form (i.e. not containing person level information).

Where can I get more information?

More information is available about Coronavirus on the State of Michigan Coronavirus website at

If you have additional questions, you can contact us at the MDHHS COVID Hotline at 1-888-535-6136.